Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Exacerbated pro‐inflammatory immune response contributes to COVID‐19 pathology. However, despite the mounting evidence about SARS‐CoV‐2 infecting the human gut, little is known about the antiviral programs triggered in this organ. To address this gap, we performed single‐cell transcriptomics of SARS‐CoV‐2‐infected intestinal organoids. We identified a subpopulation of enterocytes as the prime target of SARS‐CoV‐2 and, interestingly, found the lack of positive correlation between susceptibility to infection and the expression of ACE2 . Infected cells activated strong pro‐inflammatory programs and produced interferon, while expression of interferon‐stimulated genes was limited to bystander cells due to SARS‐CoV‐2 suppressing the autocrine action of interferon. These findings reveal that SARS‐CoV‐2 curtails the immune response and highlights the gut as a pro‐inflammatory reservoir that should be considered to fully understand SARS‐CoV‐2 pathogenesis.
Article activity feed
-
-
SciScore for 10.1101/2020.10.21.348854: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: This study was carried out in accordance with the recommendations of the University Hospital Heidelberg with informed written consent from all subjects in accordance with the Declaration of Helsinki. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Mouse monoclonal antibody against SARS-CoV NP (Sino biologicals MM05) and mouse monoclonal against J2 (scions) were diluted in phosphate-buffered saline (PBS) at 1/1000 dilution and incubated for 1h at RT. SARS-CoV NPsuggested: (Sino Biological Cat# 40143-MM05, …SciScore for 10.1101/2020.10.21.348854: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: This study was carried out in accordance with the recommendations of the University Hospital Heidelberg with informed written consent from all subjects in accordance with the Declaration of Helsinki. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Mouse monoclonal antibody against SARS-CoV NP (Sino biologicals MM05) and mouse monoclonal against J2 (scions) were diluted in phosphate-buffered saline (PBS) at 1/1000 dilution and incubated for 1h at RT. SARS-CoV NPsuggested: (Sino Biological Cat# 40143-MM05, RRID:AB_2827977)J2suggested: (US Biological Cat# U1000-87M, RRID:AB_2210756)Secondary antibody (anti-mouse CW800) and DNA dye Draq5 (Abcam) were diluted 1/10,000 in blocking buffer and incubated for 1 h at RT. anti-mouse CW800suggested: NoneDraq5suggested: NoneExperimental Models: Cell Lines Sentences Resources Viral infections: Media was removed from cells and 106 pfu of SARS-CoV-2 (as determined in Vero cells) was added to cells for 1 hour at 37°C. Verosuggested: NoneIn-cell western: 20,000 Vero E6 cells were seeded per well into a 96-well dish 24 hours prior to infection. Vero E6suggested: NoneSoftware and Algorithms Sentences Resources Targeted single-cell RNA-sequencing: For targeted scRNAseq, outer and inner primers for targeted amplification were designed using an R package for primer design described in [24] and available through Bioconductor (http://bioconductor.org/packages/release/bioc/html/TAPseq.html). Bioconductorsuggested: (Bioconductor, RRID:SCR_006442)In summary, following demultiplexing by sample, sequencing data were processed following the workflow provided by Drop-seq tools (v. 1.13, http://mccarrolllab.org/dropseq/) with STAR (v. STARsuggested: (STAR, RRID:SCR_015899)A custom script (Python v. 3.6.6) was used to filter for chimeric reads with a transcripts-per-transcript (TPT) cutoff of 0.25, and UMI observations were converted to transcript counts. Pythonsuggested: (IPython, RRID:SCR_001658)Differential expression tests were performed using MAST [47]. MASTsuggested: (MAST, RRID:SCR_016340)Subsequently, genes whose mRNAs were found to be differentially expressed were subjected to a gene set overrepresentation analysis using the EnrichR package in R. EnrichRsuggested: (Enrichr, RRID:SCR_001575)Furthermore signalling pathways enrichment was calculated using PROGENy. PROGENysuggested: (PROGENY, RRID:SCR_006647)Further brightness and contrast adjustments were performed using Fiji. Fijisuggested: (Fiji, RRID:SCR_002285)To measure the single cell fluorescent intensity for the ACE2, ISG15 and SARS-CoV-2 probes, a pipeline using CellProfiler 3.1.9 was developed. CellProfilersuggested: NoneFinally, the SARS-CoV2 mean intensity signal was plotted against the normalized ACE mean intensity signal or the ISG15 mean intensity signal using GraphPad Prism Version 6.0 GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on page 20. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
